Starting in December 2026, millions of Medicaid enrollees will be required to prove their eligibility twice as often as current rules mandate, a shift that the Urban Institute estimates could remove 2 to 3.1 million people from the program by 2028. Most of these coverage losses are projected to result from administrative lapses, such as missed filing deadlines, rather than income increases. This procedural change, embedded in the 2025 federal budget law, introduces significant risks for both beneficiaries relying on the program and investors in the managed-care companies that administer it.

Changes to Eligibility Cycles

Under the new legislation, the renewal cycle for the Medicaid expansion population—generally adults aged 19 to 64 with household income up to 138% of the federal poverty level—will shorten from 12 months to six months. States will simultaneously increase the frequency of address checks and other verifications during each review period. Traditional Medicaid groups, including children, pregnant women, and enrollees who are elderly or disabled, will remain on the annual renewal schedule.

The expansion population is the same demographic subject to the law's new 80-hour monthly work requirement. Consequently, these enrollees may face a continuous administrative burden involving eligibility paperwork, income checks, and work-hour reporting throughout the year.

Impact on Enrollment and Insurers

The accelerated renewal cycle is expected to increase "administrative churn," where eligible individuals lose coverage due to procedural errors. Historical data from the end of the pandemic-era continuous coverage provision indicates that 16.7% of Medicaid patients at community health centers experienced a gap in coverage within six months of resumed regular renewals. Doubling the frequency of renewals increases the probability of such lapses.

For investors, the primary exposure lies with managed-care companies that derive significant revenue from Medicaid. These insurers receive a set payment per member, meaning a decline in enrollment directly reduces revenue. Furthermore, frequent renewals may alter the risk pool, as healthier enrollees—who use less care and may be less attentive to mail—are more likely to drop off, leaving a proportionally sicker and more expensive member base.

Molina Healthcare has previously highlighted the impact of rising medical cost trends within its Medicaid book, a dynamic that could be exacerbated by the shift in member mix driven by more frequent redeterminations.

TD Cowen analyst Ryan Langston has maintained a Hold rating on Centene (NYSE: CNC) and raised the price target to $65 from $47. This adjustment reflects a revised valuation outlook for the healthcare company.

Rating and Target Details

The research note highlights the firm's updated stance on Centene's stock performance potential. Below is a summary of the revised metrics:

The Hold rating suggests that the stock is expected to perform in line with the broader market or sector average over the specified period.